1 Min Read What Are Immunostimulants?
July 23, 20261 Min Read What Is Immune Reprogramming?
July 23, 2026'Boost your immune system' is everywhere — but only a few things have genuine scientific backing
—— Immunostimulants: from bovine colostrum to cell therapy — separating real evidence from marketing hype.
I. The fundamental problem with 'boosting immunity': more isn't better
The immune system's optimal state isn't 'the stronger the better' — it's 'strong where it should be, restrained where it should be, balanced where it should be.' It's a highly regulated system with precise coordination of positive and negative feedback. Real-world cases: systematically 'enhancing' immunity (like early high-dose IL-2 therapy) produces life-threatening systemic toxicity — not 'immunity became stronger,' but immune activation went out of control. Autoimmune diseases (rheumatoid arthritis, SLE, multiple sclerosis) are essentially the immune system being 'too strong' — it's attacking targets it shouldn't.
So, more accurate descriptions than 'enhancing immunity' are: correcting immune function deficiency (in situations of specific function decline, filling the gap); maintaining the immune system's normal operation (providing foundational conditions so it can work efficiently); and context-specific targeted enhancement (like vaccines, enhancing specific immune memory against specific pathogens). With this framework, you'll more clearly know when, in what context, a certain intervention is meaningful, and when it's useless or even harmful.
|
If you're considering spending money on 'immune enhancement' supplements, first ask yourself: Am I exercising 150 minutes per week? Am I sleeping 7–8 hours each night? What proportion of my diet is refined sugar and ultra-processed foods? The answers to these questions matter more than any supplement. |
2. Lifestyle: the immunostimulant with the strongest evidence
Regular moderate-intensity exercise has more comprehensive randomized controlled trial evidence than any nutritional supplement for enhancing NK cell activity, maintaining T cell function, and reducing chronic inflammation. One hundred fifty minutes per week — currently the most cost-effective 'immunostimulant,' bar none. Adequate sleep (seven to eight hours, protecting deep sleep), in restoring NK cell activity, consolidating immune memory, and clearing inflammation accumulation, shows effects within days. NK cell activity declines approximately seventy percent after acute sleep deprivation — a number no supplement can easily compensate. Anti-inflammatory diet (Mediterranean dietary pattern, reducing ultra-processed foods, sufficient dietary fiber) has systematic mechanism and epidemiological evidence for lowering chronic inflammation baseline, maintaining gut immune axis, and supporting NK and T cell function. Quitting smoking is the only single behavioral intervention that simultaneously improves almost all immune function dimensions — every piece of literature on smoking and immunity concludes that quitting has systematic positive immune effects.
3. Supplements: what has evidence, in what context?
Vitamin D — one of the most clinically evidenced immune support supplements, but the key phrase is 'in deficient populations.' VITAL trial (N>25,000) shows vitamin D supplementation reduces autoimmune disease incidence by twenty-two percent; Martineau et al. meta-analysis (N>11,000) shows vitamin D supplementation significantly reduces acute respiratory tract infection incidence — but in populations with already adequate baseline levels, supplementation effects significantly diminish. Test 25-OH-D, supplement after confirming deficiency, rather than supplementing blindly.
Zinc — zinc deficiency genuinely damages immune function (NK cell activity, T cell proliferation, antibody production), with sufficient evidence for supplementation in deficient populations. Older adults (reduced digestive absorption) and vegetarians (low plant zinc absorption rate) are the populations most needing attention. But excess zinc (over 40mg per day) inhibits copper absorption, actually damaging immune function. Moderate supplementation (15–25mg per day) effective when clearly deficient. β-glucan — polysaccharides from fungal and yeast cell walls, through activating 'Trained Immunity,' can improve monocytes' and macrophages' non-specific responses to subsequent infections. Multiple clinical trials show β-glucan can reduce upper respiratory infection incidence and severity in athletes and elderly. Clear mechanism, relatively reliable evidence, but moderate effect size. Probiotics — effects highly dependent on strain, dose, administration context, and individual gut microbiome background. No single probiotic has been proven to produce consistent immune enhancement effects for all people. Most evidenced application contexts: microbiome recovery after antibiotics; prevention of certain specific pediatric infections (Lactobacillus reuteri, Lactobacillus rhamnosus GG and other specific strains).
4. Medical-grade immune enhancement: cytokine therapy and NK cell therapy
Cytokine therapy: IL-2 (interleukin-2) — high-dose IL-2 was one of the earliest FDA-approved cancer immunotherapies (1992, for metastatic renal cell carcinoma and melanoma). It produces powerful anti-tumor effects through activating NK cells and T cells. But high-dose IL-2's toxic side effects are extreme (capillary leak syndrome, often requiring ICU management), limiting widespread application. Low-dose IL-2 (for Treg cell expansion, treating autoimmune disease) is in clinical trials with better safety. IL-15 — an important survival factor for NK cells and memory T cells. IL-15 superagonists (N-803, ALT-803) have shown good NK cell activation and anti-tumor effects in clinical trials with more controllable toxicity than high-dose IL-2 — currently one of the most promising in vivo NK cell activators. IL-7 — key cytokine for thymic T cell production and peripheral T cell survival. In HIV infection, after hematopoietic stem cell transplantation, and after chemotherapy T cell reconstruction, IL-7 supplementation shows immune reconstruction promotion effects.
NK cell therapy — as introduced in detail in earlier articles, NK cell therapy represents the most direct 'functional NK cell enhancement': not activating aging NK cells, but supplementing new vigorous NK cells. This is the most direct medical response to NK cell quality decline in the elderly. BCG and trained immunity: BCG vaccine received widespread attention during COVID — epidemiological studies from the Netherlands (Mihai Netea's team) and Denmark showed that adults vaccinated with BCG in childhood had lower severe COVID rates; and among healthcare workers, BCG-vaccinated individuals had significantly higher resistance to multiple respiratory infections in subsequent months. The ACTIVATE trial (Radboud University Netherlands) — a randomized controlled trial — confirmed that within twelve months after BCG vaccination in elderly people, new infectious disease (any type) incidence was significantly lower than placebo group. This is direct clinical validation of the trained immunity concept in humans.
|
BCG vaccine is currently the most scientifically supported 'broad-spectrum non-specific immune enhancement' means. It not only prevents tuberculosis — through trained immunity, it lets your innate immune system respond faster to various future threats. This isn't an accidental finding, but a scientific fact supported by clear molecular mechanisms. |
5. How to distinguish real immune enhancement from marketing hype
Facing the dazzling array of 'immune enhancement' products on the market, the following questions can help you make wiser judgments: First: what specific immune function is it enhancing? An honest product can tell you the specific immune mechanism it affects (like 'elevating NK cell activity' or 'increasing intestinal IgA secretion'), not just saying 'boost immunity.' Second: what quality research does the evidence come from? In vitro (cell experiments) and animal experiments cannot be directly extrapolated to human effects. Truly valuable evidence is randomized controlled trials (RCT) conducted in humans, with large enough sample sizes and high enough methodological quality. Third: in what population is the effect proven? If evidence comes from populations with 'clearly impaired immune function' (like vitamin D-deficient elderly, patients undergoing chemotherapy), applying it to 'healthy populations' may significantly reduce or even eliminate the effect. Fourth: are there commercial conflicts of interest?
Frequently Asked Questions